Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM2 | Q14416 | 2/20 | 0.31 |
| ▸ | GRM3 | Q14832 | 2/20 | 0.31 |
| ▸ | GRM4 | Q14833 | 2/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | GRM8 | O00222 | 1/20 | 0.31 |
| ▸ | GRM6 | O15303 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | GRM5 | P41594 | 1/20 | 0.31 |
| ▸ | MTOR | P42345 | 1/20 | 0.31 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.31 |
| ▸ | PLCB1 | Q9NQ66 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5064896 | 1.00 | GRM2 (0.31) | GRM2GRM3GRM4CYP1A2ALOX15 | |
| Hydrochloric Acid SCHEMBL471787 | 0.98 | — | — | |
| Formic Acid SCHEMBL8030842 | 0.94 | GRM2 (0.32) | GRM2GRM3GRM4CYP1A2ALOX15 | |
| SCHEMBL5961836 | 0.93 | — | — | |
| SCHEMBL8876149 | 0.91 | — | — | |
| Lactic Acid SCHEMBL7559083 | 0.88 | TP53 (0.35) | — | |
| SCHEMBL7122613 | 0.88 | — | — | |
| SCHEMBL8103672 | 0.87 | GRM8 (0.31) | GRM2GRM3TDP1GRM8GRM6 | |
| SCHEMBL9094889 | 0.87 | — | — | |
| SCHEMBL7157746 | 0.87 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1456 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12544455-B2 | Targeted poly(beta-amino ester)s | IXAKA FRANCE (FR) | 2026-02-10 | — | — | US | claimed |
| US-20250345456-A1 | Targeted Poly(beta-amino ester)s | IXAKA FRANCE (FR) | 2025-11-13 | — | — | US | claimed |
| US-20250259837-A1 | RESPONSIVE LAYER FOR PHOTOLITHOGRAPHY FILM STACK | APPLIED MATERIALS, INC. | 2025-08-14 | — | — | US | claimed |
| US-20250161536-A1 | CLICK-CROSSLINKED HYDROGELS AND METHODS OF USE | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2025-05-22 | — | — | US | claimed |
| EP-4547291-A1 | LIGHT BEAM PROJECTION GUIDED BIOFABRICATION OF ALIGNED TISSUES | ETH Zurich (CH) | 2025-05-07 | — | — | EP | claimed |
| CN-119930418-A | Preparation method of norbornene carboxylic acid | 滨州魏桥国科高等技术研究院 | 2025-05-06 | — | — | CN | claimed |
| CN-119789880-A | Biological manufacture of directional tissue guided by beam projection | 苏黎世联邦理工学院 | 2025-04-08 | — | — | CN | claimed |
| WO-2025021165-A1 | POLYMER COMPRISING ESTER-IMIDE STRUCTURAL UNIT, AND PREPARATION METHOD THEREFOR | 西湖大学 | 2025-01-30 | — | — | WO | claimed |
| CN-118684803-A | Polydicyclopentadiene resin and preparation method thereof | 四川大学 | 2024-09-24 | — | — | CN | claimed |
| US-12053561-B2 | Click-crosslinked hydrogels and methods of use | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2024-08-06 | — | — | US | claimed |
| US-6103445-A | POLYMER OF A T-BUTYL ESTER OF NORBORNENE CARBOXYLIC ACID ANALOG, A PHOTOACID GENERATOR, AND PLASTICIZER COMPRISING A DI-TERT-BUTYL ESTER OF A POLYCYCLIC DICARBOXYLIC ACID; TRANSPARENCY AT 193 NM AND AN ETCH RESISTANCE; RESOLUTION | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2000-08-15 | — | — | US | claimed |
| US-6048664-A | Energy-sensitive resist material and a process for device fabrication using an energy-sensitive resist material | LUCENT TECHNOLOGIES, INC. (US) | 2000-04-11 | — | — | US | claimed |
| CN-1228410-A | Copolymer resin, preparation thereof, and photo resist using the same | HYUNDAI ELECTRONICS IND (KR) | 1999-09-15 | — | — | CN | claimed |
| US-5717098-A | GAMMA-LACTONE CHEMICAL INTERMEDIATE, USED TO PRODUCE A SINGLE ENANTIOMER OF AMINOAZANORADAMANTANE WHICH IS COUPLED TO AROMATIC ACID DERIVEATIVE TO PRODUCE A COMPOUND USEFUL AS 5-HT-AGONISTS OR ANTAGONSITS | G. D. SEARLE & CO. (US) | 1998-02-10 | — | — | US | claimed |
| CN-1164224-A | Monomers and composition with can be crosslinked and crosslinked polymers | CIBA GEIGY AG (CH) | 1997-11-05 | — | — | CN | claimed |
| EP-0498618-B1 | Stabilization of thiolene compositions | LOCTITE CORP (US) | 1995-04-26 | — | — | EP | claimed |
| WO-1993006171-A1 | POLYMER BLENDS OF NORBORNENE DICARBOXIMIDES | MONSANTO COMPANY (US) | 1993-04-01 | — | — | WO | claimed |
| EP-0295076-B1 | POLYOLEFINS INCORPORATING FUNCTIONAL GROUPS, MASKED FUNCTIONAL GROUP-CONTAINING MONOMERS, REACTION MIXTURES, AND METHODS FOR PREPARING SAME | EXXON CHEMICAL PATENTS INC. (US) | 1992-09-30 | — | — | EP | claimed |
| US-4987200-A | METALLIZATION BEFORE POLYMERIZATION | EXXON CHEMICAL PATENTS INC. (US) | 1991-01-22 | — | — | US | claimed |
| EP-0295076-A1 | Polyolefins incorporating functional groups, masked functional group-containing monomers, reaction mixtures, and methods for preparing same | EXXON CHEMICAL PATENTS INC. (US) | 1988-12-14 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12544455-B2 | Targeted poly(beta-amino ester)s | DNER, POTEE, BCAT1 | GRM2 4258/4885GRM3 3732/4885GRM4 4159/4885 |
| US-20250345456-A1 | Targeted Poly(beta-amino ester)s | POTEE, BCAT1, EBPL | GRM2 2896/4885GRM3 2068/4885GRM4 2190/4885 |
| US-20250161536-A1 | CLICK-CROSSLINKED HYDROGELS AND METHODS OF USE | VCL, CD44, LOX | GRM2 2990/4885GRM3 3023/4885GRM4 2780/4885 |
| US-12053561-B2 | Click-crosslinked hydrogels and methods of use | VCL, CD44, LOX | GRM2 2990/4885GRM3 3023/4885GRM4 2780/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.